Treatment Access Information by Province/Territory

Updated March 5, 2019

Kidney Cancer Canada makes every attempt to track access to medications for kidney cancer in every province. Medications are only used to treat advanced or metastatic kidney cancer at this time.

The Access to Medication by Province/Territory link below lists kidney cancer medications that are funded according to the public drug plans in each province and territory.

Some patients such as First Nations, Inuit, Canadian Forces members, RCMP, etc., may be eligible for federal programs and funding for their cancer drugs. The Non-Insured Health Benefits (NIHB) program provides supplementary health benefits, including prescription and non-prescription drugs, for registered First Nations and recognized Inuit throughout Canada, not provided through private or provincial/territorial health insurance plans. These benefits complement provincial and territorial health care programs.

Patients with private prescription drug insurance plans may have more access according to their specific prescription drug plan for their kidney cancer medications. Private prescription drug plans may cover some or all of the costs of your treatment. Please check with your individual insurance provider.

Seniors may also be eligible for extended benefits depending on the province or territory. Patients should also check with their physician regarding additional therapies that may be available to them through clinical trials across Canada.

Access to medications by Province / Territory


Patient Assistance Programs for mRCC in Canada

Kidney Cancer Canada makes every effort to stay informed about Patient Assistance Programs that may help patients access medications. In addition to the information provided here, you may find it helpful to speak with an Oncology Social Worker at your hospital or treatment centre, as there may be other financial assistance programs available to you. These Patient Assistance Programs are designed to help you access public or private insurance coverage as available to you. Patients are encouraged to call these programs to determine what help may be available in each specific situation and province or territory.

Kidney Cancer Treatment Drugs

DRUG NAME

MANUFACTURER PATIENT ASSISTANCE PROGRAM

temsirolimus
(Torisel®)
Pfizer Liaison Patient Support Program
Pfizer Canada
Telephone: 1-844-616-6888
pfizer.ca/assistance-programs
sunitinib
(Sutent®)
Pfizer Liaison Patient Support Program
Pfizer Canada
Telephone: 1-844-616-6888
pfizer.ca/assistance-programs
sorafenib
(Nexavar®)
BTHER4U Patient Support Program
Bayer Inc.
Telephone: 1-844-384-3784
everolimus
(Afinitor®)
Alliance Patient Support Program
Novartis Canada
Telephone: 1-855-489-4362
pazopanib
(Votrient®)
In Reach Patient Support Program
Novartis Canada
Telephone: 1-888-475-4255
axitinib
(Inlyta®)
Pfizer Liaison Patient Support Program
Pfizer Canada
Telephone: 1-844-616-6888
pfizer.ca/assistance-programs
lenvatinib
(Lenvima®)
Eisai Cares Lenvima Patient Support Program
Eisai Limited
Telephone: 1-877-556-8785
cabozantinib
(Cabometyx®)
Ipsen CARES Program 
Ipsen Biopharmaceuticals Canada
Telephone: 1-855-215-2288
nivolumab
(Opdivo®)
Access to Hope Program
Bristol-Myers Squibb Canada
Telephone:1-877-967-6626 
opdivo@bayshore.ca
ipilimumab
(Yervoy®)
Access to Hope Program
Bristol-Myers Squibb Canada
Telephone:1-877-967-6626 
yervoy@bayshore.ca

Supportive Care Drugs

DRUG NAME

MANUFACTURER PATIENT ASSISTANCE PROGRAM

zoledronic acid
(Zometa®)
ACCESS Patient Support Program
Novartis Canada
Telephone: 1-866-281-4765
pamidronate
(Aredia®)
Pfizer Liaison Patient Support Program
Pfizer Canada
Telephone: 1-844-616-6888
pfizer.ca/assistance-programs
denosumab
(Xgeva®)
The VICTORY Program
Amgen Canada
Telephone: 1-888-706-4717